Caustic ingestion remains a serious pediatric health problem, especially in domestic settings where corrosive substances may ...
Accidental ingestion of caustic substances can alter a child's life in an instant, damaging the esophagus and leaving lasting nutritional sequelae, ...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced additional positive results from the pivotal study of zilganersen in children and adults living with Alexander disease (AxD), a rare, ...
VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab ...
Neurocrine Biosciences, Inc. today announced the publication of the first peer-reviewed expert recommendations to guide glucocorticoid dose reduction in patients with classic congenital adrenal ...
Feeding challenges are among the most common?and stressful?issues that families with young children face. However, caregivers searching for guidance often are met with lots of conflicting, ...
FDA cleared once-daily ruxolitinib XR for MF, HU-refractory/intolerant PV, and steroid-refractory acute/chronic GVHD after ...
The potential developmental harms of AI slop are a public health concern and need more than parental controls.
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi XR™ (ruxolitinib) ...
Label expansion enables serotype-agnostic use of FcRn blockade in adult gMG, positioning both IV Vyvgart and SC Vyvgart Hytrulo as first approved options regardless of antibody status. ADAPT SERON ...
Expanded Access Program (EAP) -- $10.2 million in net reimbursements and 122 patients enrolled across multiple territories, with France contributing a stable patient base and roughly $10 million net ...
Scientists found the "brain-eating amoeba" in four locations in Yellowstone, prompting new safety concerns for visitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results